Characterization of thiobarbituric acid derivatives as inhibitors of hepatitis C virus NS5B polymerase

Virology Journal

Volumn 8, Issue , 2011, Pages

  Lee, Jong Ho ^a   Lee, Sangyoon ^a   Park, Mi Young ^a   Myung, Heejoon ^a  

^a Hankuk University of Foreign Studies   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

G05; HEPATITIS C VIRUS NS5B POLYMERASE; NONSTRUCTURAL PROTEIN 5B; RNA POLYMERASE; THIOBARBITURIC ACID DERIVATIVE; UNCLASSIFIED DRUG; ENZYME INHIBITOR; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; THIOBARBITURIC ACID; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IC 50; POLYMERIZATION; RNA BINDING; RNA SYNTHESIS; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; KOREA; METABOLISM; STRUCTURE ACTIVITY RELATION;

HEPATITIS C VIRUS;

DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; HEPACIVIRUS; HUMANS; INHIBITORY CONCENTRATION 50; KOREA; RNA, VIRAL; STRUCTURE-ACTIVITY RELATIONSHIP; THIOBARBITURATES; VIRAL NONSTRUCTURAL PROTEINS;

EID: 78651362489     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-18     Document Type: Article

References (23)

1. Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. QL Choo G Kuo AJ Weiner LR Overby DW Bradley M Houghton, Science 1989 244 359 362
2. Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. L Tomei S Altamura L Bartholomew A Biroccio A Ceccacci L Pacini F Narjes N Gennari M Bisbocci I Incitti L Orsatti S Harper I Stansfield M Rowley R De Francesco G Migliaccio, J Virol 2003 77 13225 13231
3. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. MW Fried ML Shiffman KR Reddy C Smith G Marinos FL Gonçales D Häussinger Jr M Diago G Carosi D Dhumeaux A Craxi A Lin J Hoffman J Yu, N Engl J Med 2002 347 975 982
4. Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C. LB Seeff JH Hoofnagle, Clin Liver Dis 2003 7 261 287
5. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. SE Behrens L Tomei R De Francesco, EMBO J 1996 15 12 22
6. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. V Lohmann F Körner U Herian R Bartenschlager, J Virol 1997 71 8416 8428
7. Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: Discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency. PL Beaulieu M Bos Y Bousquet P DeRoy G Fazal J Gauthier J Gillard S Goulet G McKercher M Poupart S Valois G Kukolj, Bioorg Med Chem Lett 2004 14 967 971 (Pubitemid 38167623)
8. Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: Discovery and preliminary SAR of benzimidazole derivatives. PL Beaulieu M Bos Y Bousquet G Fazal J Gauthier J Gillard S Goulet S LaPlante M Poupart S Lefebvre G McKercher C Pellerin V Austel G Kukolj, Bioorg Med Chem Lett 2004 14 119 124 (Pubitemid 38016210)
9. Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site. S Di-Marco C Volpari L Tomei S Altamura S Harper F Narjes U Koch M Rowley R De Francesco G Migliaccio A Carfí J Biol Chem 2005 280 29765 29770
10. Binding mode determination of benzimidazole inhibitors of the hepatitis C virus RNA polymerase by a structure and dynamics strategy. SR La Plante A Jakalian N Aubry Y Bousquet JM Ferland J Gillard S Lefebvre M Poirier YS Tsantrizos G Kukolj PL Beaulieu, Angew Chem In Ed 2004 43 4306 4311
11. Crystal structures of the RNA dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by nonnucleoside inhibitors. BK Biswal MM Cherney M Wang L Chan CG Yannopoulos D Bilimoria O Nicolas J Bedard MN James, J Biol Chem 2005 280 18202 18210
12. Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme. RA Love HE Parge X Yu MJ Hickey W Diehl J Gao H Wriggers A Ekker L Wang JA Thomson PS Dragovich SA Fuhrman, J Virol 2003 77 7575 7581
13. Non-nucleoside analogue inhibitors bind to an allosteric site on HCV NS5B polymerase crystal structures and mechanism of inhibition. M Wang KK Ng MM Cherney L Chan CG Yannopoulos J Bedard N Morin N Nguyen-Ba MH Alaoui-Ismaili RC Bethell MN James, J Biol Chem 2003 278 9489 9495
14. Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. D Dhanak KJ Duffy VK Johnston J Lin-Goerke M Darcy AN Shaw B Gu C Silverman AT Gates MR Nonnemacher DL Earnshaw DJ Casper A Kaura A Baker C Greenwood LL Gutshall D Maley A DelVecchio R Macarron GA Hofmann Z Alnoah HY Cheng G Chan S Khandekar RM Keenan RT Sarisky, J Biol Chem 2002 277 38322 38327
15. Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives. B Gu VK Johnston LL Gutshall TT Nguyen RR Gontarek MG Darcy R Tedesco D Dhanak KJ Duffy CC Kao RT Sarisky, J Biol Chem 2003 278 16602 16607
16. Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides. L Tomei S Altamura L Bartholomew M Bisbocci C Bailey M Bosserman A Cellucci E Forte I Incitti L Orsatti U Koch R De Francesco DB Olsen SS Carroll G Migliaccio, J Virol 2004 78 938 946
17. Partial reconstitution of hepatitis C virus RNA polymerization by heterologous expression of NS5B polymerase and template RNA in bacterial cell. S Lee J Lee Y Kee M Park H Myung, Virus Res 2005 114 158 163
18. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. V Lohmann F Körner J Koch U Herian L Theilmann R Bartenschlager, Science 1999 285 110 113
19. Methods of analyzing processivity. RA Bambara PJ Fay LM Mallaber, Methods Enzymol 1995 262 270 280
20. Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections. PL Beaulieu, Curr Opin Investig Drugs 2007 8 614 634
21. Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex. D Moradpour R Gosert D Egger F Penin HE Blum K Bienz, Antiviral Res 2003 60 103 109
22. Host factors involved in the replication of hepatitis C virus. K Moriishi Y Matsuura, Rev Med Virol 2007 17 343 354
23. Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. R Gosert D Egger V Lohmann R Bartenschlager HE Blum K Bienz D Moradpour, J Virol 2003 77 5487 5492